Register for free and gain unlimited access to our extensive elearning library
Earn CME points and track your learning activity with hundreds of hours of continuing medical education.
Share :

Management of Metastatic Renal Cell Carcinoma in Older Patients

Access the latest SIOG guidelines with our course on the management of multiple cancers in older patients. 

Our latest module focuses on the management of metastatic renal cell carcinoma in older patients. Learn what we can do to improve the standard of cancer care for older patients, understand the limitations of pivotal trials in mRCC and the future directions shaping mRCC treatment in geriatric oncology.

The information in this module is based on the position paper by Kanesvaran, R. et al 'Elderly patients with metastatic renal cell carcinoma: position paper from the International Society of Geriatric Oncology'.

Published November 2019.

Management of Metastatic Renal Cell Carcinoma in Older Patients
0 CME Points

Target audience

This module has been developed to support the daily practice of geriatric oncologists and members of the multidisciplinary team.  

Learning objectives

By the end of this module you will be able to:

Define the need and application of a Comprehensive Geriatric Assessment (CGA). 

Assess a patient's health status using the G8 screening tool.

Describe the standard lines of treatment for older patients with mRCC.

Describe the challenges around optimising sequencing of treatment. 

Describe how the future of treatment for older patients with mRCC will change including novel drugs and immunotherapy.

Apply the four-stage strategy to improve patient care.


IT Requirements

This module requires the learner to have a good, stable internet connection and can run on Internet Explorer 7 and above, Mozilla Firefox, Google Chrome and Opera on either Windows or MacOS. Flash Add-on is also required to run this module.

If you are viewing this module on an iPad (through a browser), please download the free Articulate Mobile Player beforehand. Other tablet devices may not be compatible - please check for Flash compatibility.

If you are experiencing technical difficulties, please contact and we will get back to you as soon as possible.

Disclosure policy

ecancer and Dr Ravindran Kanesvaran, Division of Medical Oncology, National Cancer Centre Singapore, Singapore, have no actual or potential conflict of interest whatsoever which impinges on the making, peer reviewing and dissemination of this e-learning module which was made possible through an unrestricted educational grant from Pfizer.

For more information please contact


Production of this module was funded by the International Society of Geriatric Oncology (SIOG) and by an unrestricted grant from Pfizer.